In another study, the cancer-immune dynamics resulting from interleukin-2 (IL-2) or adoptive cell transfer (ACT) immunotherapy was described [119,120], suggesting that a small increase in antigenicity led to significant variations in tumor size. This evidence concerns the gene IL2 and neoplasm.